supplemental figure 1. chemical structures of hydroxamic ......supplemental figure 1. chemical...

20
Supplemental Data. Venturelli et al. (2015). Plant Cell 10.1105/tpc.15.00585 1 Supplemental Figure 1. Chemical structures of hydroxamic acid HDAC inhibitors and allelochemicals. TSA SAHA DIBOA DIMBOA BOA MBOA APO AMPO Hydroxamic acids Cyclic hydroxamic acids Derivatives of cyclic hydroxamic acids

Upload: others

Post on 28-Mar-2020

12 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Supplemental Figure 1. Chemical structures of hydroxamic ......Supplemental Figure 1. Chemical structures of hydroxamic acid HDAC inhibitors and allelochemicals. TSA SAHA DIBOA DIMBOA

Supplemental Data. Venturelli et al. (2015). Plant Cell 10.1105/tpc.15.00585

1

Supplemental Figure 1. Chemical structures of hydroxamic acid HDAC inhibitors and allelochemicals.

TSA SAHA

DIBOA DIMBOA

BOA MBOA

APO AMPO

Hydroxamic acids

Cyclic hydroxamic acids

Derivatives of cyclic hydroxamic acids

Page 2: Supplemental Figure 1. Chemical structures of hydroxamic ......Supplemental Figure 1. Chemical structures of hydroxamic acid HDAC inhibitors and allelochemicals. TSA SAHA DIBOA DIMBOA

Supplemental Data. Venturelli et al. (2015). Plant Cell 10.1105/tpc.15.00585

2

Supplemental Figure 2. HDAC conservation across different organism. Multiple sequence alignments of HDACs of Homo sapiens (Hs), Aquifex aeolicus (Aa) and A. thaliana (At). Between human HDAC8 and HDAC4 most of the active site is conserved. In HDAC8 the hydroxyl group of Tyr306 forms a hydrogen bond to an oxygen atom of hydroxamic acid inhibitors (Somoza et al., 2004), whereas in HDAC4 the equivalent Tyr is replaced by His and the bond is formed by a water molecule (Bottomley et al., 2008). A tyrosine in A. thaliana HDA1/HDA19, HDA2 and HDA6 makes this part of the binding site more similar to HDAC8. In the central part of the binding site, His142, His143 and Phe152 are identical across species; Phe208 is

Page 3: Supplemental Figure 1. Chemical structures of hydroxamic ......Supplemental Figure 1. Chemical structures of hydroxamic acid HDAC inhibitors and allelochemicals. TSA SAHA DIBOA DIMBOA

Supplemental Data. Venturelli et al. (2015). Plant Cell 10.1105/tpc.15.00585

3

replaced by Tyr in HDA2. For clarity, only the central part of the alignment, as present in the crystal structure of HDAC8 (PDB-ID 1T64), is shown. Blue circles below the alignment: zinc binding site; green boxes below the alignment: residues predicted to bind to APO or AMPO in HDAC8. Figure drawn with ESPript.

Page 4: Supplemental Figure 1. Chemical structures of hydroxamic ......Supplemental Figure 1. Chemical structures of hydroxamic acid HDAC inhibitors and allelochemicals. TSA SAHA DIBOA DIMBOA

Supplemental Data. Venturelli et al. (2015). Plant Cell 10.1105/tpc.15.00585

4

Supplemental Figure 3. Modeled binding of known and putative HDAC inhibitors to human and bacterial HDACs. A-C, TSA (green), SAHA (yellow), APO (red) and AMPO (blue), with crystal structure reference coordinates of TSA (atom colors), in the binding pocket of human class I HDAC8 (A), human class II HDAC4 (B) and bacterial HDLP (C) (all HDACs in surface representation). Residues with predicted interactions with the ligands are shown in stick representation; the zinc ion of the HDAC is shown as a grey sphere. Water molecules are shown in stick representation (black arrows). Figures were rendered with BALLView and POVRay (v3.6).

HDAC8 HDAC8

HDAC4 HDAC4

HDLP HDLP

A

B

C

Page 5: Supplemental Figure 1. Chemical structures of hydroxamic ......Supplemental Figure 1. Chemical structures of hydroxamic acid HDAC inhibitors and allelochemicals. TSA SAHA DIBOA DIMBOA

Supplemental Data. Venturelli et al. (2015). Plant Cell 10.1105/tpc.15.00585

5

Supplemental Figure 4. Homology models of A. thaliana HDACs. Class I HDA6 (A) and class II HDA2 (B) are shown in cartoon representation (red), compared to the template structure of bacterial HDLP (transparent grey). View into the binding site with the zinc ion at the bottom (grey sphere), indicating the high conservation of secondary structure elements of the binding site (center).

A

B

HDA6

HDA2

Page 6: Supplemental Figure 1. Chemical structures of hydroxamic ......Supplemental Figure 1. Chemical structures of hydroxamic acid HDAC inhibitors and allelochemicals. TSA SAHA DIBOA DIMBOA

Supplemental Data. Venturelli et al. (2015). Plant Cell 10.1105/tpc.15.00585

6

Supplemental Figure 5. DIBOA, DIMBOA, BOA and MBOA do not inhibit plant-derived HDAC enzymes. Overall HDAC inhibition in nuclear extracts of A. thaliana by increasing concentrations of DIBOA, DIMBOA, BOA and MBOA (5, 20, 50, 100 and 200 µM); SAHA (50 µM) was used as a reference inhibitor. Data points represent the mean ± SD of 4 individual measurements (two independent experiments, each performed in duplicate).

0 50 100 150 200

-250

255075

100DIBOADIMBOABOAMBOASAHA

DIBOA

Concentration (µM)

HD

AC in

hibi

tion

(%)

BOA APO

DIMBOA MBOA AMPOOxidationHydrolysis

Page 7: Supplemental Figure 1. Chemical structures of hydroxamic ......Supplemental Figure 1. Chemical structures of hydroxamic acid HDAC inhibitors and allelochemicals. TSA SAHA DIBOA DIMBOA

Supplemental Data. Venturelli et al. (2015). Plant Cell 10.1105/tpc.15.00585

7

Supplemental Figure 6. Inhibition of human class I, II and IV HDAC enzymes by APO. Human HDAC profiling was performed for different concentrations of APO (5, 20, 100 and 200 µM). Red horizontal line indicates 50% inhibition of HDAC activity. Data points represent the mean ± SD of 4 individual measurements (two independent experiments, each performed in duplicate).

HDAC1

0 50 100 150 200

0

25

50

75

100

Concentration (µM)

HD

AC

inhib

itio

n (

%) HDAC2

0

25

50

75

100

HDAC3

0

25

50

75

100

HDAC4 HDAC5 HDAC6

HDAC7 HDAC8 HDAC9

HDAC10 HDAC11

0 50 100 150 200

Concentration (µM)

0 50 100 150 200

Concentration (µM)

0

25

50

75

100

HD

AC

inhib

itio

n (

%)

25

50

75

100

25

50

75

100

0

25

50

75

100

HD

AC

inhib

itio

n (

%)

0

25

50

75

100

0

25

50

75

100

0

25

50

75

100

HD

AC

inhib

itio

n (

%)

0

25

50

75

100

0 50 100 150 200

Concentration (µM)

0 50 100 150 200

Concentration (µM)

0 50 100 150 200

Concentration (µM)

0 50 100 150 200

Concentration (µM)

0 50 100 150 200

Concentration (µM)

0 50 100 150 200

Concentration (µM)

0 50 100 150 200

Concentration (µM)

0 50 100 150 200

Concentration (µM)

Page 8: Supplemental Figure 1. Chemical structures of hydroxamic ......Supplemental Figure 1. Chemical structures of hydroxamic acid HDAC inhibitors and allelochemicals. TSA SAHA DIBOA DIMBOA

Supplemental Data. Venturelli et al. (2015). Plant Cell 10.1105/tpc.15.00585

8

Supplemental Figure 7. Inhibition of human class I, II and IV HDAC enzymes by AMPO. Human HDAC profiling was performed for different concentrations of AMPO (5, 20, 100 and 200 µM). Red horizontal line highlights 50% inhibition of HDAC activity. Data points indicate the mean ± SD of 4 individual measurements (two independent experiments, each performed in duplicate).

0

25

50

75

100

HD

AC

inhib

itio

n (

%)

0

25

50

75

100

HD

AC

inhib

itio

n (

%)

0

25

50

75

100

HD

AC

inhib

itio

n (

%)

0

25

50

75

100

HD

AC

inhib

itio

n (

%)

0

25

50

75

100

0

25

50

75

100

0

25

50

75

100

0

25

50

75

100

0

25

50

75

100

0

25

50

75

100

0

25

50

75

100

0 50 100 150 200

Concentration (µM)

0 50 100 150 200

Concentration (µM)

0 50 100 150 200

Concentration (µM)

0 50 100 150 200

Concentration (µM)

0 50 100 150 200

Concentration (µM)

0 50 100 150 200

Concentration (µM)

0 50 100 150 200

Concentration (µM)

0 50 100 150 200

Concentration (µM)

0 50 100 150 200

Concentration (µM)

0 50 100 150 200

Concentration (µM)

0 50 100 150 200

Concentration (µM)

HDAC1 HDAC2 HDAC3

HDAC4 HDAC5 HDAC6

HDAC7 HDAC8 HDAC9

HDAC10 HDAC11

Page 9: Supplemental Figure 1. Chemical structures of hydroxamic ......Supplemental Figure 1. Chemical structures of hydroxamic acid HDAC inhibitors and allelochemicals. TSA SAHA DIBOA DIMBOA

Supplemental Data. Venturelli et al. (2015). Plant Cell 10.1105/tpc.15.00585

9

Supplemental Figure 8. Exposure to hydroxamic acids and their derivatives inhibits plant growth in lettuce. Concentration-response assays for APO and AMPO on root growth of L. sativa seedlings. The commercially available herbicide PEN was used as a positive control. Root length was measured 5 days after germination (≥ 1 mm minimum root length) and concentration-response curves were calculated using a logistic regression model. The quality of curve fitting was verified by F test for lack-of-fit based on an analysis of variances (α=0.05).

0.0

0.2

0.4

0.6

0.8

1.0

1.2

101 102 103

Rela

tive r

oot le

ngth

Concentration (mM)

APO

AMPO

PEN

100 10-1 10-2 10-3 0

Page 10: Supplemental Figure 1. Chemical structures of hydroxamic ......Supplemental Figure 1. Chemical structures of hydroxamic acid HDAC inhibitors and allelochemicals. TSA SAHA DIBOA DIMBOA

Supplemental Data. Venturelli et al. (2015). Plant Cell 10.1105/tpc.15.00585

10

Supplemental Figure 9. Growth defects in HDAC loss-of-function mutants. Seedlings were grown for 7 days on half-strength MS medium after stratification at 4°C for 4 days; the exact alleles used are indicated in the Methods section.

Ws-2

Col-0

Wildtype hda19

Wildtype hda6-6 hda6-710

mm

Page 11: Supplemental Figure 1. Chemical structures of hydroxamic ......Supplemental Figure 1. Chemical structures of hydroxamic acid HDAC inhibitors and allelochemicals. TSA SAHA DIBOA DIMBOA

Supplemental Data. Venturelli et al. (2015). Plant Cell 10.1105/tpc.15.00585

11

Supplemental Figure 10. Validation of ChIP enrichment for H3ac by quantitative real-time PCR. Relative enrichment of acetylated histone H3 was determined by qRT-PCR using specific primers for loci previously identified as acetylated (TUB2) or not acetylated (AT1TE46405) locus (Supplemental Table 2) (Wang et al., 2015). For each chromatin extract, ChIPs were performed sequentially using anti-acetylated histone H3 and anti-H3 antibodies. Levels of H3ac are given as percentages of IP/input relative to histone H3 occupancy.

0

0.04

0.08

0.12

0.16

Control APO TSARel

ativ

e H

3 ac

etyl

atio

n AT5G62690(TUB2), Replicate 1 AT5G62690 (TUB2), Replicate 2 AT1TE46405, Replicate 1 AT1TE46405, Replicate 2

Page 12: Supplemental Figure 1. Chemical structures of hydroxamic ......Supplemental Figure 1. Chemical structures of hydroxamic acid HDAC inhibitors and allelochemicals. TSA SAHA DIBOA DIMBOA

Supplemental Data. Venturelli et al. (2015). Plant Cell 10.1105/tpc.15.00585

12

Supplemental Figure 11. Schematic representation of the ChIP peak calling and filtering. Peaks were called independently from two biological replicates using MACS2, and subjected to IDR (irreproducibility discovery rate) (Li et al., 2011) analysis to filter for reliably detected peaks. Moreover, alignments of each replicate were split into two self-pseudoreplicates and each pair of self-pseudoreplicates was subjected to IDR filtering. In parallel, reads of the two biological replicates were pooled and peaks were called on the pooled dataset. Finally, the merged alignments were split into two pseudoreplicates and subjected to the same peak calling and filtering process. Only peaks called in all three sets were used for differential analysis. N1, N2, Np and Nt represent the number of peaks retained after the respective filtering and were used for quality assessment (Supplemental Table 3). Scheme modified from Landt et al. (2012).

Page 13: Supplemental Figure 1. Chemical structures of hydroxamic ......Supplemental Figure 1. Chemical structures of hydroxamic acid HDAC inhibitors and allelochemicals. TSA SAHA DIBOA DIMBOA

Supplemental Data. Venturelli et al. (2015). Plant Cell 10.1105/tpc.15.00585

13

Supplemental Figure 12. Differential ChIP-seq analysis. A, Principal component analyses (PCA) of histone acetylation. The left panel is based on acetylation at all analyzed peaks; the right panel shows PCA on peaks identified as differentially acetylated between APO- and non-APO-treated samples using the edgeR implementation of the DiffBind package. Percentages in square brackets represent the amount of variation explained by the respective principal component. B-C, Manhattan plots of differential ChIP-seq analysis of APO- (B) and TSA-treated (C) samples compared to the untreated control using the DiffBind package. Red dots indicate statistically significantly differentially acetylated peaks (FDR <0.1). Left and right panels show results using the edgeR and DESeq2 implementations in DiffBind, respectively. D, Venn diagrams showing the overlap of differentially acetylated peaks upon APO and TSA treatment using the edgeR or DESeq2 implementations in DiffBind.

Page 14: Supplemental Figure 1. Chemical structures of hydroxamic ......Supplemental Figure 1. Chemical structures of hydroxamic acid HDAC inhibitors and allelochemicals. TSA SAHA DIBOA DIMBOA

Supplemental Data. Venturelli et al. (2015). Plant Cell 10.1105/tpc.15.00585

14

Supplemental Figure 13. Correlation between TSA-dependent gene expression and H3 acetylation. H3 acetylation in control-, TSA- and APO-treated samples at peaks overlapping with TSA-upregulated (left panel) and TSA-downregulated genes (right panel). (RPKM: Reads Per Kilobase per Million; * p<0.05, unpaired two-tailed Student’s t-test; ns: not significant).

Control TSA APO0

20

40

60

80

Control TSA APO0

20

40

60

TSA-upregulated genes TSA-downregulated genes

nsns

nsns

*

ns

His

tone

H3

acet

ylat

ion

(RP

KM

)

His

tone

H3

acet

ylat

ion

(RP

KM

) 80

Page 15: Supplemental Figure 1. Chemical structures of hydroxamic ......Supplemental Figure 1. Chemical structures of hydroxamic acid HDAC inhibitors and allelochemicals. TSA SAHA DIBOA DIMBOA

Supplemental Data. Venturelli et al. (2015). Plant Cell 10.1105/tpc.15.00585

15

Supplemental Figure 14. Annotation of acetylated and differentially acetylated regions. A, All positions in the respective set of regions were assigned to one annotation element in the following order: CDS > intron > 5’UTR > 3’UTR > 2 kb upstream > 2 kb downstream > transposon (TE) > intergenic. Annotation was based on the TAIR10 model of A. thaliana gene annotation, for TEs we used the annotation of Slotte et al. (2013). B, Histograms of χ2 test statistics. Left panel: from the unified set of H3ac peaks, n1 randomly drawn peaks were compared against n2 randomly drawn peaks, n1 and n2 corresponding to the number of APO- and TSA-hyper-acetylated regions, respectively. The red line indicates the test statistic of the real-data comparison of APO-hyper-acetylated regions to TSA-hyper-acetylated regions. Right panel: same as left panel, but for hypo-acetylated regions.

Co

ntr

ol

TS

A

AP

O

TS

A h\SHUí$

F

TS

A h\SRí$F

AP

O h\SHUí$

F

AP

O h\SRí$F

Re

lativH�Fo

ve

rag

e

0.0

0.2

0.4

0.6

0.8

1.02kb upstream

5'UTR

CDS

Intron

3'UTR

2kb downstream

Transposon

,QWHUJHQLF

ȋ2 THVW�VWDWLVWLF

)UHTXHQF\

0 5 10 15 20 25 30

01

00

20

03

00

40

0

ȋ2 THVW�VWDWLVWLF0 5 10 15 20 25 30

$32�YV��76$�K\SHUDFHW\ODWLRQ $32�YV��76$�K\SRDFHW\ODWLRQ

Random peaks

$32�YV��76$�K\SR�$FRandom peaks

APO vs. TSA

K\SHU�$F

A

B

Page 16: Supplemental Figure 1. Chemical structures of hydroxamic ......Supplemental Figure 1. Chemical structures of hydroxamic acid HDAC inhibitors and allelochemicals. TSA SAHA DIBOA DIMBOA

Supplemental Data. Venturelli et al. (2015). Plant Cell 10.1105/tpc.15.00585

16

Supplemental Figure 15. Summary of gene ontology (GO) term analysis of differentially expressed genes. Heatmap showing p-values of ‘molecular function’ and ‘cellular component’ GO terms that were over-represented in at least one treatment. Black color indicates that the respective GO term was not significantly over-representated.

iron ion bindingWKUHRQLQHíW\SH�HQGRSHSWLGDVH�DFWLYLW\trDQVferDVH�DFWLYLW\, trDQVferring he[RV\O�JURXSVnXFOHRVLGHíWrLSKRVSKDWDVH�DFWLYLW\HOHFWURQ�FDUrLHU�DFWLYLW\JOXWDWKLRQH�ELQGLQJdrXJ�WrDQVPHPErDQH�WrDQVSRrWHU�DFWLYLW\HQGRSHSWLGDVH�DFWLYLW\DQWLSRrWHU�DFWLYLW\DGHn\O\OíVXOfDWH�UHGXFWDVH�DFWLYLW\ATPDVH�DFWLYLW\ATPDVH�DFWLYLW\��FRXSOHG�WR�WrDQVPHPErDQH�PoYHPHQW�RI�VXEVWDQFHVo[\JHQ�ELQGLQJ8'3íJO\FRV\OWrDQVferDVH�DFWLYLW\8'3íJOXFRV\OWrDQVferDVH�DFWLYLW\o[LGRUHGXFWDVH�DFWLYLW\JOXWDWKLRQH�WrDQVferDVH�DFWLYLW\LQGROHí�íDFHWRQLWrLOH�QLWrLODVH�DFWLYLW\nitrLODVH�DFWLYLW\KHPH�ELQGLQJSHUo[LGDVH�DFWLYLW\o[LGRUHGXFWDVH�DFWLYLW\��DFWLQJ�RQ�SDLUHG�GRQRUV, with

Molecular function

� � �ORJ���S�YDOXH�

F\WRVROSURWHDVRPH�FRUH�FRPSOexFHOO�wDOOYDFXRODU�PHPErDQHF\WRSODVPSURWHDVRPH�FRPSOexDSRSODVWFKORURSODVWextrDFHOOXODU�UHJLRQ

6$+$BXS

SA

HA

_dow

n76

$BXS

TSA

_dow

n$32BXS

AP

O_d

own

Cellular component

Page 17: Supplemental Figure 1. Chemical structures of hydroxamic ......Supplemental Figure 1. Chemical structures of hydroxamic acid HDAC inhibitors and allelochemicals. TSA SAHA DIBOA DIMBOA

Supplemental Data. Venturelli et al. (2015). Plant Cell 10.1105/tpc.15.00585

17

Supplemental Figure 16. Validation of RNAseq by quantitative real-time PCR. From genes classified as differentially expressed upon APO treatment, 6 genes were randomly chosen for validation by reverse transcription followed by quantitative PCR (qRT-PCR). Bars represent the mean of RNA-seq read counts; the four individual replicates are shown by black circles. The expression fold-change, determined by qRT-PCR relative to the control sample, is shown by the red line. Filled triangles represent the mean, empty triangles represent the three biological replicates. RNA-seq and qRT-PCR data are represented to scale; the RNA-seq control level was set to 1 for qRT-PCR fold changes.

AT1G11190

Norm

alized r

ead c

ount (R

NA

seq)

Control TSA APO

050

100

0.2

0.4

0.6

0.8

1.0

1.2

AT2G23680

040

80

1.0

1.5

2.0

2.5

3.0

3.5

AT4G33070

0200

400

600

800

2

4

6

8

10

12

AT2G34300

Norm

alized r

ead c

ount (R

NA

seq)

0100

200

300

400

500

0.2

0.4

0.6

0.8

1.0

AT4G19880

02000

4000

5

10

15

AT3G14420

02000

4000

6000

0.4

0.6

0.8

1.0

1.2

Fold

change (q

PC

R)

Fold

change (q

PC

R)

Control TSA APO Control TSA APO

Control TSA APO Control TSA APO Control TSA APO

Page 18: Supplemental Figure 1. Chemical structures of hydroxamic ......Supplemental Figure 1. Chemical structures of hydroxamic acid HDAC inhibitors and allelochemicals. TSA SAHA DIBOA DIMBOA

Supplemental Data. Venturelli et al. (2015). Plant Cell 10.1105/tpc.15.00585

18

Compound EC10 (µM) EC50 (µM) EC70 (µM) EC90 (µM)APO 7 75 192 856AMPO 1491 4724 7369 14966PEN 51 664 1782 8597

Lactuca sativaCompound EC10 (µM) EC50 (µM) EC70 (µM) EC90 (µM)

APO 2896 6868 9582 16289AMPO 3623 12291 19685 41694PEN 9 14 16 20

Arabidopsis thaliana

Supplemental Table 1. Effective concentrations for different HDAC inhibitors. EC-concentrations causing a 10, 50, 70 and 90% inhibition in root length of A. thaliana Col-0 and L. sativa cv. Maikönig for APO and AMPO, as calculated using a logistic concentration-response model. For comparison the EC50-values of the commercial herbicide PEN are also presented.

TAIR10 Gene ID Gene name Direction Sequence (5'->3')AT5G62690 TUB2 forward AAGAACCATGCACTCATCAGCAT5G62690 TUB2 reverse ATCCGTGAAGAGTACCCAGATAT1G37110 AT1TE46405 forward CTGCGTGGAAGTCTGTCAAAAT1G37110 AT1TE46405 reverse CTATGCCACAGGGCAGTTTT

Supplemental Table 2. Primer sequences for chromatin immunoprecipitation analyses.

Sample N1/N2 Np/NtReplicate1 Replicate2

APO 39686 48141 1.81 2.85TSA 28325 32629 1.21 1.80Control 23913 41660 1.58 1.58

Number of peaks

Supplemental Table 3. Quality control analysis of ChIP peak calling. Quality control parameters were calculated as indicated in Supplemental Figure 10. Nt/Np and N1/N2 reference values as used in the ENCODE project, details are described in Landt et al. (2012).

Page 19: Supplemental Figure 1. Chemical structures of hydroxamic ......Supplemental Figure 1. Chemical structures of hydroxamic acid HDAC inhibitors and allelochemicals. TSA SAHA DIBOA DIMBOA

Supplemental Data. Venturelli et al. (2015). Plant Cell 10.1105/tpc.15.00585

19

TAIR10 Gene ID Gene name Direction Sequence (5'->3')

AT1G11190 BFN1 forward GGGATACAAAGGCGTCAAGTCTGAT1G11190 BFN1 reverse GTGGCAGCAACACCAGCAATAGAT2G23680 n/a forward CGCTCTCCTCACCGTTATTCTCAGAT2G23680 n/a reverse TCCCGTATATCTCAGGTCGTCTCTGAT4G33070 PDC1 forward GGTCTCGTTGACGCCATTCATAACAT4G33070 PDC1 reverse CTTTCTTCTCCGTCGTCGCTGTCAT2G34300 n/a forward CCATGCCGATCATCTTTTCTCTACCAT2G34300 n/a reverse TTCTCCTAATGTTTCCATGTCATCCCAT4G19880 n/a forward TGCAAAGAAACAAGGACCTTATGAGAT4G19880 n/a reverse TTTCAGTCAAAGTGTTACCACAGATGAT3G14420 GOX1 forward TGTTCGACGTGGCACTGATGTCAT3G14420 GOX1 reverse CCTTTCTAACTCCAGCCTCTCCTTC

Supplemental Table 4. Primer sequences for RNA-seq validation by qRT-PCR.

Page 20: Supplemental Figure 1. Chemical structures of hydroxamic ......Supplemental Figure 1. Chemical structures of hydroxamic acid HDAC inhibitors and allelochemicals. TSA SAHA DIBOA DIMBOA

Supplemental Data. Venturelli et al. (2015). Plant Cell 10.1105/tpc.15.00585

20

SUPPLEMENTAL REFERENCES

Bottomley, M.J., Lo Surdo, P., Di Giovine, P., Cirillo, A., Scarpelli, R., Ferrigno, F., Jones, P., Neddermann, P., De Francesco, R., Steinkuhler, C., Gallinari, P., and Carfi, A. (2008). Structural and functional analysis of the human HDAC4 catalytic domain reveals a regulatory structural zinc-binding domain. J Biol Chem 283, 26694-26704.

Landt, S.G., Marinov, G.K., Kundaje, A., Kheradpour, P., Pauli, F., Batzoglou, S., Bernstein, B.E., Bickel, P., Brown, J.B., Cayting, P., Chen, Y., DeSalvo, G., Epstein, C., Fisher-Aylor, K.I., Euskirchen, G., Gerstein, M., Gertz, J., Hartemink, A.J., Hoffman, M.M., Iyer, V.R., Jung, Y.L., Karmakar, S., Kellis, M., Kharchenko, P.V., Li, Q., Liu, T., Liu, X.S., Ma, L., Milosavljevic, A., Myers, R.M., Park, P.J., Pazin, M.J., Perry, M.D., Raha, D., Reddy, T.E., Rozowsky, J., Shoresh, N., Sidow, A., Slattery, M., Stamatoyannopoulos, J.A., Tolstorukov, M.Y., White, K.P., Xi, S., Farnham, P.J., Lieb, J.D., Wold, B.J., and Snyder, M. (2012). ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia. Genome Res 22, 1813-1831.

Li, Q., Brown, J., Huang, H., and Bickel, P. (2011). Measuring reproducibility of high-throughput experiments. Ann Appl Stat 5, 1752–1779.

Slotte, T., Hazzouri, K.M., Agren, J.A., Koenig, D., Maumus, F., Guo, Y.L., Steige, K., Platts, A.E., Escobar, J.S., Newman, L.K., Wang, W., Mandakova, T., Vello, E., Smith, L.M., Henz, S.R., Steffen, J., Takuno, S., Brandvain, Y., Coop, G., Andolfatto, P., Hu, T.T., Blanchette, M., Clark, R.M., Quesneville, H., Nordborg, M., Gaut, B.S., Lysak, M.A., Jenkins, J., Grimwood, J., Chapman, J., Prochnik, S., Shu, S., Rokhsar, D., Schmutz, J., Weigel, D., and Wright, S.I. (2013). The Capsella rubella genome and the genomic consequences of rapid mating system evolution. Nat Genet 45, 831-835.

Somoza, J.R., Skene, R.J., Katz, B.A., Mol, C., Ho, J.D., Jennings, A.J., Luong, C., Arvai, A., Buggy, J.J., Chi, E., Tang, J., Sang, B.C., Verner, E., Wynands, R., Leahy, E.M., Dougan, D.R., Snell, G., Navre, M., Knuth, M.W., Swanson, R.V., McRee, D.E., and Tari, L.W. (2004). Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases. Structure 12, 1325-1334.

Wang, C., Liu, C., Roqueiro, D., Grimm, D., Schwab, R., Becker, C., Lanz, C., and Weigel, D. (2015). Genome-wide analysis of local chromatin packing in Arabidopsis thaliana. Genome Res 25, 246-256.